Hodges Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-12,385
| Closed | -$358K | – | 217 |
|
2024
Q3 | $358K | Sell |
12,385
-1,246
| -9% | -$36.1K | 0.02% | 191 |
|
2024
Q2 | $381K | Buy |
13,631
+1,504
| +12% | +$42.1K | 0.03% | 189 |
|
2024
Q1 | $337K | Buy |
12,127
+1,752
| +17% | +$48.7K | 0.02% | 193 |
|
2023
Q4 | $299K | Buy |
10,375
+4,248
| +69% | +$122K | 0.02% | 191 |
|
2023
Q3 | $203K | Buy |
+6,127
| New | +$203K | 0.02% | 205 |
|
2023
Q2 | – | Hold |
0
| – | – | – | 176 |
|
2023
Q1 | – | Sell |
-13,929
| Closed | -$714K | – | 226 |
|
2022
Q4 | $714K | Sell |
13,929
-11,599
| -45% | -$595K | 0.06% | 164 |
|
2022
Q3 | $1.12M | Sell |
25,528
-9,608
| -27% | -$420K | 0.18% | 115 |
|
2022
Q2 | $1.84M | Sell |
35,136
-30,143
| -46% | -$1.58M | 0.19% | 103 |
|
2022
Q1 | $3.38M | Sell |
65,279
-42,166
| -39% | -$2.18M | 0.27% | 98 |
|
2021
Q4 | $6.35M | Buy |
107,445
+10,871
| +11% | +$642K | 0.46% | 77 |
|
2021
Q3 | $4.15M | Buy |
96,574
+89,384
| +1,243% | +$3.84M | 0.31% | 90 |
|
2021
Q2 | $282K | Buy |
7,190
+1,658
| +30% | +$65K | 0.03% | 211 |
|
2021
Q1 | $200K | Buy |
+5,532
| New | +$200K | 0.03% | 209 |
|
2019
Q1 | – | Sell |
-4,835
| Closed | -$200K | – | 243 |
|
2018
Q4 | $200K | Buy |
+4,835
| New | +$200K | 0.02% | 215 |
|
2017
Q4 | – | Sell |
-5,954
| Closed | -$202K | – | 264 |
|
2017
Q3 | $202K | Buy |
+5,954
| New | +$202K | 0.01% | 243 |
|
2017
Q1 | – | Sell |
-6,523
| Closed | -$201K | – | 294 |
|
2016
Q4 | $201K | Sell |
6,523
-5,559
| -46% | -$171K | 0.01% | 265 |
|
2016
Q3 | $388K | Buy |
12,082
+571
| +5% | +$18.3K | 0.02% | 222 |
|
2016
Q2 | $385K | Buy |
11,511
+3,882
| +51% | +$130K | 0.02% | 214 |
|
2016
Q1 | $215K | Buy |
7,629
+128
| +2% | +$3.61K | 0.01% | 251 |
|
2015
Q4 | $230K | Buy |
+7,501
| New | +$230K | 0.01% | 245 |
|